Literature DB >> 25241045

Sleep disordered breathing as measured by SRBD-PSQ and neurocognition in children with hypertension.

Marc B Lande1, Stephen R Hooper2, Donald L Batisky3, Juan C Kupferman4, Peter G Szilagyi5, Joshua A Samuels6, Heather R Adams7.   

Abstract

BACKGROUND: Cognitive test performance is decreased in hypertensive adults and children, a finding postulated to represent early target-organ damage to the brain. Hypertensive children are often obese, a comorbidity associated with sleep disordered breathing (SDB), itself associated with cognitive problems; potentially confounding the relation between hypertension (HTN) and neurocognition. Our objective was to determine the association between SDB as measured by a scale and questionnaire score and neurocognition among participants enrolled in an ongoing multicenter study of cognition in children with HTN.
METHODS: Subjects completed laboratory-based neurocognitive tests. Parents and subjects completed rating scales of executive function, mood, and behavior problems. Parents completed the Sleep-Related Breathing Disorder scale of the Pediatric Sleep Questionnaire (SRBD-PSQ).
RESULTS: To date, 38 HTN subjects and 34 control subjects have completed neurocognitive testing and the SRBD-PSQ. Median SRBD-PSQ scores were similar between groups but the HTN group had a higher percentage of subjects with SRBD-PSQ scores in the range suggestive of obstructive sleep apnea (26% vs. 6%, P = 0.03). Overall, higher SRBD-PSQ scores were not significantly associated with worse performance on laboratory-based measures of executive function and other cognitive domains but were significantly associated with worse scores on rating scales of executive function as well as mood and behavior problems.
CONCLUSIONS: A larger proportion of children with HTN had scores suggestive of SDB. The results underscore the importance of using a multi-method approach in the assessment of cognition and adjusting for potential confounding effects of SDB in studies of cognition in hypertensive children. © American Journal of Hypertension, Ltd 2014. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  blood pressure; cognition; executive function; hypertension; sleep apnea.

Mesh:

Year:  2014        PMID: 25241045      PMCID: PMC4425836          DOI: 10.1093/ajh/hpu180

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  25 in total

1.  The Behavior Rating Inventory of Executive Function: commentary.

Authors:  Martha Bridge Denckla
Journal:  Child Neuropsychol       Date:  2002-12       Impact factor: 2.500

2.  The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents.

Authors: 
Journal:  Pediatrics       Date:  2004-08       Impact factor: 7.124

3.  Practice effects associated with the repeated assessment of cognitive function using the CogState battery at 10-minute, one week and one month test-retest intervals.

Authors:  Marina G Falleti; Paul Maruff; Alexander Collie; David G Darby
Journal:  J Clin Exp Neuropsychol       Date:  2006-10       Impact factor: 2.475

4.  Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study.

Authors:  Marc B Lande; Nancy L Carson; Jason Roy; Cecilia C Meagher
Journal:  Hypertension       Date:  2006-05-30       Impact factor: 10.190

5.  Pediatric sleep questionnaire (PSQ): validity and reliability of scales for sleep-disordered breathing, snoring, sleepiness, and behavioral problems.

Authors: 
Journal:  Sleep Med       Date:  2000-02-01       Impact factor: 3.492

6.  Prevalence of overweight and obesity in the United States, 1999-2004.

Authors:  Cynthia L Ogden; Margaret D Carroll; Lester R Curtin; Margaret A McDowell; Carolyn J Tabak; Katherine M Flegal
Journal:  JAMA       Date:  2006-04-05       Impact factor: 56.272

7.  Reduced cerebral blood flow response and compensation among patients with untreated hypertension.

Authors:  J R Jennings; M F Muldoon; C Ryan; J C Price; P Greer; K Sutton-Tyrrell; F M van der Veen; C C Meltzer
Journal:  Neurology       Date:  2005-04-26       Impact factor: 9.910

Review 8.  Obesity and obstructive sleep apnea in children.

Authors:  Riva Tauman; David Gozal
Journal:  Paediatr Respir Rev       Date:  2006-10-30       Impact factor: 2.726

9.  Hypopnea in pediatric patients with obesity hypertension.

Authors:  Erin Parrish Reade; Craig Whaley; Jen-Jar Lin; Daniel W McKenney; Daniel Lee; Ronald Perkin
Journal:  Pediatr Nephrol       Date:  2004-06-04       Impact factor: 3.714

10.  Relationships between cognitive and behavioral measures of executive function in children with brain disease.

Authors:  Vicki A Anderson; Peter Anderson; Elisabeth Northam; Rani Jacobs; Ola Mikiewicz
Journal:  Child Neuropsychol       Date:  2002-12       Impact factor: 2.500

View more
  5 in total

Review 1.  Cognitive function in hypertensive children.

Authors:  Marc B Lande; Juan C Kupferman
Journal:  Curr Hypertens Rep       Date:  2015-01       Impact factor: 5.369

2.  Severe obstructive sleep apnea in children with elevated blood pressure.

Authors:  Jane Hinkle; Heidi V Connolly; Heather R Adams; Marc B Lande
Journal:  J Am Soc Hypertens       Date:  2018-01-03

3.  Sleep disordered breathing symptoms and daytime sleepiness are associated with emotional problems and poor school performance in children.

Authors:  Jianghong Liu; Xianchen Liu; Xiaopeng Ji; Yingjie Wang; Guoping Zhou; Xinyin Chen
Journal:  Psychiatry Res       Date:  2016-05-24       Impact factor: 3.222

Review 4.  The pressure's on: understanding neurocognitive and psychological associations with pediatric hypertension to inform comprehensive care.

Authors:  Anne E Dawson; Mahmoud Kallash; John D Spencer; Camille S Wilson
Journal:  Pediatr Nephrol       Date:  2021-04-22       Impact factor: 3.714

5.  Effect of Adenotonsillectomy on Attention in Korean Children With Sleep-Disordered Breathing.

Authors:  Min Jae Kim; Sung Hee Bae; Sung Min Lee; Kang Hyun Lee; Dong-Kyu Kim
Journal:  Clin Exp Otorhinolaryngol       Date:  2018-05-18       Impact factor: 3.372

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.